141 related articles for article (PubMed ID: 29448931)
1. Effects of different extracts of curcumin on TPC1 papillary thyroid cancer cell line.
Perna A; De Luca A; Adelfi L; Pasquale T; Varriale B; Esposito T
BMC Complement Altern Med; 2018 Feb; 18(1):63. PubMed ID: 29448931
[TBL] [Abstract][Full Text] [Related]
2. Curcumin induces endoplasmic reticulum stress-associated apoptosis in human papillary thyroid carcinoma BCPAP cells via disruption of intracellular calcium homeostasis.
Zhang L; Cheng X; Xu S; Bao J; Yu H
Medicine (Baltimore); 2018 Jun; 97(24):e11095. PubMed ID: 29901626
[TBL] [Abstract][Full Text] [Related]
3. Effects of curcumin and its adjuvant on TPC1 thyroid cell line.
Esposito T; Lucariello A; Hay E; Contieri M; Tammaro P; Varriale B; Guerra G; De Luca A; Perna A
Chem Biol Interact; 2019 May; 305():112-118. PubMed ID: 30935902
[TBL] [Abstract][Full Text] [Related]
4. Induction of ROS-independent DNA damage by curcumin leads to G2/M cell cycle arrest and apoptosis in human papillary thyroid carcinoma BCPAP cells.
Zhang L; Cheng X; Gao Y; Bao J; Guan H; Lu R; Yu H; Xu Q; Sun Y
Food Funct; 2016 Jan; 7(1):315-25. PubMed ID: 26442630
[TBL] [Abstract][Full Text] [Related]
5. Curcumin inhibits invasion and metastasis in K1 papillary thyroid cancer cells.
Zhang CY; Zhang L; Yu HX; Bao JD; Sun Z; Lu RR
Food Chem; 2013 Aug; 139(1-4):1021-8. PubMed ID: 23561205
[TBL] [Abstract][Full Text] [Related]
6. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-β/Smad2/3 signaling pathway.
Zhang L; Cheng X; Gao Y; Zhang C; Bao J; Guan H; Yu H; Lu R; Xu Q; Sun Y
Exp Cell Res; 2016 Feb; 341(2):157-65. PubMed ID: 26826337
[TBL] [Abstract][Full Text] [Related]
8. Curcumin Inhibits Papillary Thyroid Cancer Cell Proliferation by Regulating lncRNA LINC00691.
Li Z; Gao Y; Li L; Xie S
Anal Cell Pathol (Amst); 2022; 2022():5946670. PubMed ID: 35256924
[TBL] [Abstract][Full Text] [Related]
9. Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway.
Khan AQ; Ahmed EI; Elareer N; Fathima H; Prabhu KS; Siveen KS; Kulinski M; Azizi F; Dermime S; Ahmad A; Steinhoff M; Uddin S
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936675
[TBL] [Abstract][Full Text] [Related]
10. High doses of hydroxytyrosol induce apoptosis in papillary and follicular thyroid cancer cells.
Toteda G; Lupinacci S; Vizza D; Bonofiglio R; Perri E; Bonofiglio M; Lofaro D; La Russa A; Leone F; Gigliotti P; Cifarelli RA; Perri A
J Endocrinol Invest; 2017 Feb; 40(2):153-162. PubMed ID: 27592355
[TBL] [Abstract][Full Text] [Related]
11. Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells.
Schwertheim S; Wein F; Lennartz K; Worm K; Schmid KW; Sheu-Grabellus SY
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1143-1154. PubMed ID: 28265769
[TBL] [Abstract][Full Text] [Related]
12. The mechanism underlying proliferation-inhibitory and apoptosis-inducing effects of curcumin on papillary thyroid cancer cells.
Song F; Zhang L; Yu HX; Lu RR; Bao JD; Tan C; Sun Z
Food Chem; 2012 May; 132(1):43-50. PubMed ID: 26434261
[TBL] [Abstract][Full Text] [Related]
13. Curcumin inhibits proliferation and invasion of papillary thyroid carcinoma cells by inhibiting the JAK2 / STAT3 pathway.
Hu Y; Zhou N; Zhu Q
J BUON; 2021; 26(4):1635-1641. PubMed ID: 34565029
[TBL] [Abstract][Full Text] [Related]
14. Curcumin induces mitophagy by promoting mitochondrial succinate dehydrogenase activity and sensitizes human papillary thyroid carcinoma BCPAP cells to radioiodine treatment.
Zhang L; Qiu L; Xu S; Cheng X; Wu J; Wang Y; Gao W; Bao J; Yu H
Toxicol In Vitro; 2023 Dec; 93():105669. PubMed ID: 37634662
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer activity of myricetin against human papillary thyroid cancer cells involves mitochondrial dysfunction-mediated apoptosis.
Ha TK; Jung I; Kim ME; Bae SK; Lee JS
Biomed Pharmacother; 2017 Jul; 91():378-384. PubMed ID: 28463801
[TBL] [Abstract][Full Text] [Related]
16. A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.
Lin SF; Lin JD; Hsueh C; Chou TC; Wong RJ
PLoS One; 2017; 12(2):e0172315. PubMed ID: 28207834
[TBL] [Abstract][Full Text] [Related]
17. The mTOR Kinase Inhibitor CZ415 Inhibits Human Papillary Thyroid Carcinoma Cell Growth.
Li X; Li Z; Song Y; Liu W; Liu Z
Cell Physiol Biochem; 2018; 46(2):579-590. PubMed ID: 29617677
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits hypoxia-induced migration in K1 papillary thyroid cancer cells.
Tan C; Zhang L; Cheng X; Lin XF; Lu RR; Bao JD; Yu HX
Exp Biol Med (Maywood); 2015 Jul; 240(7):925-35. PubMed ID: 25349216
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved.
Bian P; Hu W; Liu C; Li L
Arch Biochem Biophys; 2020 Aug; 689():108461. PubMed ID: 32531316
[TBL] [Abstract][Full Text] [Related]
20. Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death.
Goncalves AP; Videira A; Maximo V; Soares P
J Biosci; 2011 Sep; 36(4):639-48. PubMed ID: 21857110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
